225 related articles for article (PubMed ID: 29152605)
1. Hepatic Natural Killer T-cell and CD8+ T-cell Signatures in Mice with Nonalcoholic Steatohepatitis.
Bhattacharjee J; Kirby M; Softic S; Miles L; Salazar-Gonzalez RM; Shivakumar P; Kohli R
Hepatol Commun; 2017 Jun; 1(4):299-310. PubMed ID: 29152605
[TBL] [Abstract][Full Text] [Related]
2. Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice.
Cuño-Gómiz C; de Gregorio E; Tutusaus A; Rider P; Andrés-Sánchez N; Colell A; Morales A; Marí M
Biol Sex Differ; 2023 Nov; 14(1):85. PubMed ID: 37964320
[TBL] [Abstract][Full Text] [Related]
3. A comparative study on roles of natural killer T cells in two diet-induced non-alcoholic steatohepatitis-related fibrosis in mice.
Zheng S; Yang W; Yao D; Tang S; Hou J; Chang X
Ann Med; 2022 Dec; 54(1):2233-2245. PubMed ID: 35950602
[TBL] [Abstract][Full Text] [Related]
4. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.
Kohli R; Kirby M; Xanthakos SA; Softic S; Feldstein AE; Saxena V; Tang PH; Miles L; Miles MV; Balistreri WF; Woods SC; Seeley RJ
Hepatology; 2010 Sep; 52(3):934-44. PubMed ID: 20607689
[TBL] [Abstract][Full Text] [Related]
5. High-trans fatty acid and high-sugar diets can cause mice with non-alcoholic steatohepatitis with liver fibrosis and potential pathogenesis.
Xin X; Cai BY; Chen C; Tian HJ; Wang X; Hu YY; Feng Q
Nutr Metab (Lond); 2020; 17():40. PubMed ID: 32508961
[TBL] [Abstract][Full Text] [Related]
6. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
Locatelli I; Sutti S; Vacchiano M; Bozzola C; Albano E
Clin Sci (Lond); 2013 Feb; 124(4):279-87. PubMed ID: 22970906
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.
Syn WK; Oo YH; Pereira TA; Karaca GF; Jung Y; Omenetti A; Witek RP; Choi SS; Guy CD; Fearing CM; Teaberry V; Pereira FE; Adams DH; Diehl AM
Hepatology; 2010 Jun; 51(6):1998-2007. PubMed ID: 20512988
[TBL] [Abstract][Full Text] [Related]
8. Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis.
Ibrahim SH; Gores GJ; Hirsova P; Kirby M; Miles L; Jaeschke A; Kohli R
Liver Int; 2014 Mar; 34(3):427-37. PubMed ID: 24256559
[TBL] [Abstract][Full Text] [Related]
9. Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis.
Maricic I; Marrero I; Eguchi A; Nakamura R; Johnson CD; Dasgupta S; Hernandez CD; Nguyen PS; Swafford AD; Knight R; Feldstein AE; Loomba R; Kumar V
J Immunol; 2018 Nov; 201(10):3017-3035. PubMed ID: 30322964
[TBL] [Abstract][Full Text] [Related]
10. The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis.
Wang T; Sun G; Wang Y; Li S; Zhao X; Zhang C; Jin H; Tian D; Liu K; Shi W; Tian Y; Zhang D
FASEB J; 2019 Jul; 33(7):8490-8503. PubMed ID: 30951375
[TBL] [Abstract][Full Text] [Related]
11. Prolonged-release pirfenidone prevents obesity-induced cardiac steatosis and fibrosis in a mouse NASH model.
Gutiérrez-Cuevas J; Sandoval-Rodríguez A; Monroy-Ramírez HC; Vazquez-Del Mercado M; Santos-García A; Armendáriz-Borunda J
Cardiovasc Drugs Ther; 2021 Oct; 35(5):927-938. PubMed ID: 32621046
[TBL] [Abstract][Full Text] [Related]
12. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
[TBL] [Abstract][Full Text] [Related]
13. TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice.
Yang L; Miura K; Zhang B; Matsushita H; Yang YM; Liang S; Song J; Roh YS; Seki E
Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):469-483. PubMed ID: 28462384
[TBL] [Abstract][Full Text] [Related]
14. CD8
Breuer DA; Pacheco MC; Washington MK; Montgomery SA; Hasty AH; Kennedy AJ
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G211-G224. PubMed ID: 31709830
[TBL] [Abstract][Full Text] [Related]
15. Pitavastatin ameliorated the progression of steatohepatitis in ovariectomized mice fed a high fat and high cholesterol diet.
Kamada Y; Kiso S; Yoshida Y; Chatani N; Kizu T; Hamano M; Egawa M; Takemura T; Ezaki H; Furuta K; Hayashi N; Takehara T
Hepatol Res; 2013 Apr; 43(4):401-12. PubMed ID: 22971151
[TBL] [Abstract][Full Text] [Related]
16. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
[TBL] [Abstract][Full Text] [Related]
17. Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease.
Leung C; Herath CB; Jia Z; Andrikopoulos S; Brown BE; Davies MJ; Rivera LR; Furness JB; Forbes JM; Angus PW
World J Gastroenterol; 2016 Sep; 22(35):8026-40. PubMed ID: 27672297
[TBL] [Abstract][Full Text] [Related]
18. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
[TBL] [Abstract][Full Text] [Related]
19. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet.
Kamada Y; Kiso S; Yoshida Y; Chatani N; Kizu T; Hamano M; Tsubakio M; Takemura T; Ezaki H; Hayashi N; Takehara T
Am J Physiol Gastrointest Liver Physiol; 2011 Dec; 301(6):G1031-43. PubMed ID: 21885686
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
Min-DeBartolo J; Schlerman F; Akare S; Wang J; McMahon J; Zhan Y; Syed J; He W; Zhang B; Martinez RV
PLoS One; 2019; 14(12):e0226854. PubMed ID: 31891606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
